A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Clinical trial NCT02571036 · COMPLETED

Trial details

NCT number: NCT02571036
Sponsor: Deciphera Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors Advanced Systemic Mastocytosis Advanced Cancers

Start date: 2015-11-01
Primary completion: 2022-04-29
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.